6 results
2021 ACR/VF Guidelines for Management of Giant Cell Arteritis (GCA)

#GiantCell #Arteritis #GCA #ACR2021 #Management #rheumatology #algorithm
Guidelines for Management ... Arteritis (GCA) #GiantCell ... Arteritis #GCA #ACR2021 ... #Management #rheumatology ... #algorithm #vasculitis
2021 ACR/VF Guidelines for Management of Eosinophilic Granulomatosis with Polyangiitis (EGPA)

#EGPA #Eosinophilic #Granulomatosis #Polyangiitis #ACR2021 #Management
Guidelines for Management ... of Eosinophilic ... #Polyangiitis #ACR2021 ... #Management #rheumatology ... #algorithm #vasculitis
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Vasculitis Management ... Polyangiitis (MPA) • Eosinophilic ... @MithuRheum #Vasculitis ... #ACR2021 #Guidelines ... #algorithm #rheumatology
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Eosinophilic Granulomatosis ... (EGPA) - ANCA Vasculitis ... Management Algorithm ... #ACR2021 #Guidelines ... #algorithm #rheumatology
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
Arteritis (GCA) - Vasculitis ... Management Algorithm ... @MithuRheum #GiantCell ... #ACR2021 #Guidelines ... #algorithm #rheumatology
IgG4-Related Disease
Clinical history:  Man, 60 years, multiorgan involvement, unique or multiple inflammatory pseudotumor
4 phenotypes:
 •
relapse No specific laboratory ... phase reactants, eosinophilia ... No necrosis, No vasculitis ... Disease #diagnosis #management ... #phenotypes #workup